Zhang L, Reith ME
A 2025 pilot study evaluated intravenous BPC-157 at 10 mg and 20 mg doses in two healthy adults, finding no adverse effects on cardiac, hepatic, renal, thyroid, or metabolic biomarkers
C: Cells, exposed to UV radiation as above, were collected and the number of Trypan blue-negative (live) cells was determined
( k ) RAD51 foci were quantified in Kuramochi cells treated with cisplatin alone or in combination with KG, l-carnitine, or O-acetyl-l-carnitine (n = 3 technical replicates representative from 2 independent experiments)
It can help reduce pain levels and improve quality of life
also discovered that this injection was able to relieve hypoxia and unexpectedly also found that, when used in combination with checkpoint blockade therapy, tumors at distant sites were reduced, meaning that this treatment also has promising potential for tumor metastasis (Yang et al., 2017)